Patents by Inventor Robert N. Young

Robert N. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260097041
    Abstract: In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes, bone loss, and cancer, using a compound of Formula I.
    Type: Application
    Filed: May 8, 2025
    Publication date: April 9, 2026
    Inventors: Debra ELLIES, F. Scott KIMBALL, Robert N. YOUNG
  • Publication number: 20250304584
    Abstract: In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.
    Type: Application
    Filed: November 8, 2024
    Publication date: October 2, 2025
    Inventors: Debra Ellies, F. Scott Kimball, Robert N. Young
  • Publication number: 20250263428
    Abstract: The present invention relates to conjugate compounds and methods of making and using same.
    Type: Application
    Filed: April 21, 2022
    Publication date: August 21, 2025
    Inventors: Marion THEVENIN, Robert N. YOUNG, Gang CHEN
  • Patent number: 12324809
    Abstract: In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes, bone loss, and cancer, using a compound of Formula I.
    Type: Grant
    Filed: January 17, 2024
    Date of Patent: June 10, 2025
    Assignee: OSSIFI THERAPEUTICS LLC
    Inventors: Debra Ellies, F. Scott Kimball, Robert N. Young
  • Publication number: 20250025472
    Abstract: In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes, bone loss, and cancer, using a compound of Formula I.
    Type: Application
    Filed: January 17, 2024
    Publication date: January 23, 2025
    Inventors: Debra Ellies, F. Scott Kimball, Robert N. Young
  • Patent number: 12195461
    Abstract: In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.
    Type: Grant
    Filed: March 7, 2023
    Date of Patent: January 14, 2025
    Assignee: OssiFi Therapeutics LLC
    Inventors: Debra Ellies, F. Scott Kimball, Robert N. Young
  • Patent number: 11903949
    Abstract: In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes, bone loss, and cancer, using a compound of Formula I.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: February 20, 2024
    Assignee: OSSIFI THERAPEUTICS LLC
    Inventors: Debra Ellies, F. Scott Kimball, Robert N. Young
  • Publication number: 20230203036
    Abstract: In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.
    Type: Application
    Filed: March 7, 2023
    Publication date: June 29, 2023
    Inventors: Debra ELLIES, F. Scott Kimball, Robert N. Young
  • Patent number: 11655250
    Abstract: In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: May 23, 2023
    Assignee: OsteoQC Inc.
    Inventors: Debra Ellies, F. Scott Kimball, Robert N. Young
  • Publication number: 20220242893
    Abstract: The present invention relates to conjugate compounds and methods of making and using same.
    Type: Application
    Filed: April 21, 2022
    Publication date: August 4, 2022
    Inventors: Marion THÉVENIN, Robert N. YOUNG, Gang CHEN
  • Patent number: 11312737
    Abstract: The present invention relates to EP4 agonist-bisphosphonate conjugates or related compounds and uses thereof. Said conjugates or related compounds may be used to provide delivery of an EP4 agonist or related compound to a desired site of action, such as a bone. Bisphosphonate moieties, linked to the EP4 agonists via amide linkers, have been implicated in the inhibition of bone resorption and bone targeting.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: April 26, 2022
    Assignee: SIMON FRASER UNIVERSITY
    Inventors: Marion Thévenin, Robert N. Young, Gang Chen
  • Publication number: 20220024922
    Abstract: In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.
    Type: Application
    Filed: February 26, 2021
    Publication date: January 27, 2022
    Inventors: Debra ELLIES, F. Scott Kimball, Robert N. Young
  • Patent number: 10947236
    Abstract: In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: March 16, 2021
    Assignee: OsteoQC Inc.
    Inventors: Debra Ellies, F. Scott Kimball, Robert N. Young
  • Publication number: 20210024464
    Abstract: This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
    Type: Application
    Filed: January 28, 2020
    Publication date: January 28, 2021
    Inventors: Paul RENNIE, Artem TCHERKASSOV, Robert N. YOUNG, Christophe M. ANDRE
  • Patent number: 10633338
    Abstract: This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: April 28, 2020
    Assignees: THE UNIVERSITY OF BRITISH COLUMBIA, SIMON FRASER UNIVERSITY
    Inventors: Paul Rennie, Artem Tcherkassov, Robert N. Young, Christophe M. Andre
  • Publication number: 20200055853
    Abstract: In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.
    Type: Application
    Filed: August 13, 2019
    Publication date: February 20, 2020
    Inventors: Debra ELLIES, F. Scott Kimball, Robert N. Young
  • Publication number: 20200054645
    Abstract: In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes, bone loss, and cancer, using a compound of Formula I.
    Type: Application
    Filed: August 13, 2019
    Publication date: February 20, 2020
    Inventors: Debra ELLIES, F. Scott Kimball, Robert N. Young
  • Publication number: 20190345179
    Abstract: The present invention relates to EP4 agonist-bisphosphonate conjugates or related compounds and uses thereof. Said conjugates or related compounds may be used to provide delivery of an EP4 agonist or related compound to a desired site of action, such as a bone. Bisphosphonate moieties, linked to the EP4 agonists via amide linkers, have been implicated in the inhibition of bone resorption and bone targeting.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 14, 2019
    Inventors: Marion THÉVENIN, Robert N. YOUNG, Gang CHEN
  • Publication number: 20190300480
    Abstract: This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
    Type: Application
    Filed: May 30, 2019
    Publication date: October 3, 2019
    Inventors: Paul RENNIE, Artem TCHERKASSOV, Robert N. YOUNG, Christophe M. ANDRE
  • Patent number: D866581
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: November 12, 2019
    Assignee: Reliance Medical Products, Inc.
    Inventors: Robert N. Young, Gregory F. Bellamah, Deepak Sridhara